Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MLYCD | O95822 | 1/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | GPR6 | P46095 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.32 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15671140 | 0.93 | MLYCD (0.40) | MLYCDRXFP1GPR6HDAC8ALDH1A1 | |
| SCHEMBL29379234 | 0.93 | MLYCD (0.40) | MLYCDRXFP1GPR6HDAC8ALDH1A1 | |
| SCHEMBL16863608 | 0.92 | MLYCD (0.39) | MLYCDRXFP1GPR6HDAC8ALDH1A1 | |
| SCHEMBL17829478 | 0.89 | MLYCD (0.37) | MLYCDRXFP1HDAC8ALDH1A1LMNA | |
| SCHEMBL16870221 | 0.88 | GPR6 (0.37) | MLYCDGPR6ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL17178350 | 0.88 | MLYCD (0.43) | MLYCDRXFP1GPR6HDAC8ALDH1A1 | |
| SCHEMBL17178329 | 0.88 | MLYCD (0.43) | MLYCDRXFP1GPR6ALDH1A1LMNA | |
| SCHEMBL19513092 | 0.85 | MLYCD (0.41) | MLYCDRXFP1GPR6HDAC8ALDH1A1 | |
| SCHEMBL17178360 | 0.85 | MLYCD (0.41) | MLYCDRXFP1GPR6ALDH1A1LMNA | |
| SCHEMBL20233493 | 0.85 | MLYCD (0.41) | MLYCDRXFP1GPR6HDAC8ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9598369-B2 | Process for the preparation of amides from hindered anilines containing a perhaloalkyl group | SYNGENTA PARTICIPATIONS AG (CH) | 2017-03-21 | — | — | US | disclosed |
| US-20160168097-A1 | PROCESS FOR THE PREPARATION OF AMIDES FROM HINDERED ANILINES CONTAINING A PERHALOALKYL GROUP | SYNGENTA PARTICIPATIONS AG (CH) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168097-A1 | PROCESS FOR THE PREPARATION OF AMIDES FROM HINDERED ANILINES CONTAINING A PERHALOALKYL GROUP | ABHD5, FADS1, PFAS | MLYCD 1591/4885RXFP1 3588/4885GPR6 2083/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.